These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12893209)

  • 21. Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients.
    Yamamoto K; Oogi S; Inoue H; Kudoh K; Kita T; Kikuchi Y
    Curr Med Chem; 2004 Feb; 11(4):425-8. PubMed ID: 14965223
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma.
    Rollins SE; Young RH; Bell DA
    Am J Surg Pathol; 2006 Apr; 30(4):457-62. PubMed ID: 16625091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of ovarian cancer stage IV and advanced rectal cancer responding to paclitaxel/carboplatin].
    Kawaguchi R; Furukawa N; Morimoto Y; Ohi M; Osawa T; Koike H; Miyake T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):619-22. PubMed ID: 15114712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fertility Preservation Is Safe for Serous Borderline Ovarian Tumors.
    Vancraeynest E; Moerman P; Leunen K; Amant F; Neven P; Vergote I
    Int J Gynecol Cancer; 2016 Oct; 26(8):1399-406. PubMed ID: 27465897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncologic Concerns regarding Laparoscopic Cytoreductive Surgery in Patients with Advanced Ovarian Cancer Submitted to Neoadjuvant Chemotherapy.
    Favero G; Macerox N; Pfiffer T; Köhler C; da Costa Miranda V; Estevez Diz Mdel P; Fukushima JT; Baracat EC; Carvalho JP
    Oncology; 2015; 89(3):159-66. PubMed ID: 25968072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Secondary surgery in patients with serous low malignant potential ovarian tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Duvillard P; Morice P
    Int J Gynecol Cancer; 2010 Apr; 20(3):346-52. PubMed ID: 20375795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ovarian serous borderline tumors with invasive peritoneal implants.
    Gershenson DM; Silva EG; Levy L; Burke TW; Wolf JK; Tornos C
    Cancer; 1998 Mar; 82(6):1096-103. PubMed ID: 9506355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes.
    Scott SA; Llaurado Fernandez M; Kim H; Elit L; Nourmoussavi M; Glaze S; Roberts L; Offman SL; Rahimi K; Lytwyn A; Sur M; Gilks CB; Matheson K; Köbel M; Dawson A; Tinker AV; Kwon JS; Hoskins P; Santos JL; Cheung A; Provencher D; Carey MS;
    Gynecol Oncol; 2020 Apr; 157(1):36-45. PubMed ID: 32001076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic factors in patients with ovarian serous low malignant potential (borderline) tumors with peritoneal implants.
    Kane A; Uzan C; Rey A; Gouy S; Camatte S; Pautier P; Lhommé C; Haie-Meder C; Duvillard P; Morice P
    Oncologist; 2009 Jun; 14(6):591-600. PubMed ID: 19487334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcome of patients with advanced-stage borderline ovarian tumors after a first peritoneal noninvasive recurrence: impact on further management.
    Uzan C; Zanini-Grandon AS; Bentivegna E; Gouy S; Leary A; Duvillard P; Morice P
    Int J Gynecol Cancer; 2015 Jun; 25(5):830-6. PubMed ID: 25828751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
    Tang L; Zheng M; Xiong Y; Ding H; Liu FY
    Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of random biopsies, omentectomy, and hysterectomy in operations for borderline ovarian tumors.
    Kristensen GS; Schledermann D; Mogensen O; Jochumsen KM
    Int J Gynecol Cancer; 2014 Jun; 24(5):874-9. PubMed ID: 24844221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.
    Leary A; Petrella MC; Pautier P; Duvillard P; Uzan C; Tazi Y; Ledoux F; Gouy S; Morice P; Lhommé C
    Gynecol Oncol; 2014 Jan; 132(1):23-7. PubMed ID: 24219980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study.
    Barnhill DR; Kurman RJ; Brady MF; Omura GA; Yordan E; Given FT; Kucera PR; Roman LD
    J Clin Oncol; 1995 Nov; 13(11):2752-6. PubMed ID: 7595734
    [TBL] [Abstract][Full Text] [Related]  

  • 36. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
    Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
    Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fertility results and outcomes after pure laparoscopic management of advanced-stage serous borderline tumors of the ovary.
    Kane A; Uzan C; Gouy S; Pautier P; Duvillard P; Morice P
    Fertil Steril; 2010 Dec; 94(7):2891-4. PubMed ID: 20537629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial ovarian tumors of borderline malignancy.
    Chao TM; Yen MS; Chao KC; Ng HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Aug; 58(2):97-102. PubMed ID: 8915111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy.
    Morice P; Joulie F; Rey A; Atallah D; Camatte S; Pautier P; Thoury A; Lhommé C; Duvillard P; Castaigne D
    Eur J Gynaecol Oncol; 2004; 25(2):169-74. PubMed ID: 15032274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival after paclitaxel plus platinum-based combination chemotherapy for extraovarian peritoneal serous papillary carcinoma: is it different from that for ovarian serous papillary cancer?
    Ayhan A; Taskiran C; Yigit-Celik N; Bozdag G; Gultekin M; Usubutun A; Guler N; Yuce K
    Int J Gynecol Cancer; 2006; 16(2):484-9. PubMed ID: 16681715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.